52320-59-9 Usage
Uses
Used in Pharmaceutical Research:
5-Ethyl-isoxazole-3-carboxylic acid is utilized as a starting material for the synthesis of various drug candidates and biologically active compounds. Its unique structure and functional groups make it a valuable component in the creation of novel therapeutic agents.
Used in Organic Synthesis:
As a versatile intermediate, 5-Ethyl-isoxazole-3-carboxylic acid is employed in the organic synthesis of a wide range of chemical products, including pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Antimicrobial Applications:
5-Ethyl-isoxazole-3-carboxylic acid has been studied for its potential antimicrobial properties, making it a candidate for use in the development of new antimicrobial agents to combat resistant strains of bacteria.
Used in Anti-inflammatory Applications:
5-ETHYL-ISOXAZOLE-3-CARBOXYLIC ACID has also been investigated for its anti-inflammatory properties, suggesting its potential use in the development of anti-inflammatory drugs to treat various inflammatory conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 52320-59-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,3,2 and 0 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 52320-59:
(7*5)+(6*2)+(5*3)+(4*2)+(3*0)+(2*5)+(1*9)=89
89 % 10 = 9
So 52320-59-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H7NO3/c1-2-4-3-5(6(8)9)7-10-4/h3H,2H2,1H3,(H,8,9)
52320-59-9Relevant academic research and scientific papers
SUBSTITUTED PIPERIDINE COMPOUNDS
-
Paragraph 0360, (2016/06/01)
The present disclosure provides substituted piperidine compounds having Formula (I), and the pharmaceutically acceptable salts and solvates thereof, wherein R1, B, X, and Z are defined as set forth in the specification. The present disclosure i
Positive allosteric modulators of the nicotinic acetylcholine receptor
-
Page 47, 48, (2010/02/05)
The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals used to treat diseases or conditions in which α7 nAChR is known to be involved.
Isoxazole derivatives
-
, (2008/06/13)
Isoxazole derivatives represented by the formula: STR1 are prepared; wherein R1 and R2 each is hydrogen atom, alkyl group of 1 to 8 carbon atoms, or cycloalkyl group of 3 to 10 carbon atoms; R3 and R4 each is hydrogen atom, alkyl group of 1 to 8 carbon atoms, cycloalkyl group of 3 to 10 carbon atoms, or phenyl group; or the group Is morpholino group; and Y is oxo group, thioxo group or imino group; being useful as a hypoglycemic and/or a blood free-fatty-acid normalizing antidiabetic agent.
